Changes in Plasma Fibronectin Levels After Cardiac and Pulmonary Surgery: Role of Cardiopulmonary Bypass

Publisher Website
Google Scholar
Abstract
The changes in immunoassayable plasma fibronectin were studied during seven days after cardiac surgery with cardiopulmonary bypass (group A, 19 patients) or lung surgery without bypass (group B, 11 patients). In group A the fibronectin showed a series of rapid changes during the 24 perioperative hours. Simultaneous assessment of other plasma proteins (albumin, fibrinogen and immunoglobulin G) suggested that these changes mainly reflected hemodilution and hemoconcentration processes following the cardiopulmonary bypass, being influenced by the necessarily large transfusions of plasma. The fibronectin level decreased after day 1, with maximum depletion (averaging -32% of preoperative value) on day 3. Despite subsequent progressive rise, full restoration had not been reached by day 7. Group B did not show the initial rapid changes, but progressive fall in fibronectin level to a nadir on day 2 (-20% of preoperative) was followed by gradual return to outset value on days 4–5. The study demonstrated 1) that cardiac cr lung surgery induces transient fibronectin depletion on days 2 to 3 postoperatively, and 2) that in surgery with cardiopulmonary bypass the decrease is significantly greater and more prolonged. It is proposed that this supplementary decrease is due to the large amounts of particulates of various origin entering the blood during the bypass.